Ikaria, Inc, a biotherapeutics company, has appointed Craig Tooman as senior vice president (SVP) and chief financial officer (CFO). In this role, Tooman will be responsible for all financial functions of the company, as well as for information technology services. He succeeds Elizabeth Larkin, who left the company in March to pursue other interests. He will assume his new role at the beginning of August.
Tooman has over 20 years of experience in the pharmaceutical industry, and joins Ikaria from Enzon Pharmaceuticals, where he was executive vice president of finance and CFO since 2005. Prior to joining Enzon, he served as SVP of strategic planning and corporate communications at ILEX Oncology, which was acquired by Genzyme in 2004. He also played a significant role in the 2001 merger between Pharmacia & Upjohn and Monsanto that created the Pharmacia Corporation, having served in various positions within its predecessor companies Pharmacia & Upjohn and The Upjohn Company. Tooman holds an MBA from the University of Chicago, and a BA from Kalamazoo College.
The annual BNP Paribas Cash Management University kicked off on Thursday morning with treasury professionals congregating in Paris from across Europe.
APIs may be a solution to MT940 challenges, says Karen Fagan, treasury operation manager, for British television company, ITV.
Kicking off the first day of the Singapore Fintech Festival, issues with cryptocurrencies were addressed by MIT media labs director, Joi Ito, and panels of technology leaders discussed how they’re using data analytics.
Sibos 2017 day two highlights: Brexit and banking, and why ‘data is the new oil’ in financial services
How nation first politics can impact global financial organisations It’s clear that data and regulation are the two key topics that are ... read more